Evidence map›Paper›PMID 26712979›Full record

ArticleAnesthesia, essays and researches

Does the preoperative administration of tranexamic acid reduce perioperative blood loss and transfusion requirements after head neck cancer surgery? A randomized, controlled trial.

Anjan Das, Surajit Chattopadhyay, Debabrata Mandal, Subinay Chhaule, Tapobrata Mitra, Anindya Mukherjee, Subrata Kumar Mandal, Sandip Chattopadhyay

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in Anesthesia, essays and researches. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Tranexamic acid in otorhinolaryngology - A contemporary review.World journal of otorhinolaryngology - head and neck surgery · 2021
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Anjan DasDepartment of Anaesthesiology, College of Medicine and Sagore Dutta Hospital, Berhampore, West Bengal, India.
Surajit ChattopadhyayDepartment of Anaesthesiology, College of Medicine and Sagore Dutta Hospital, Berhampore, West Bengal, India.
Debabrata MandalDepartment of Oral and Maxillofacial Surgery, Dr. R. Ahmed Dental College, Berhampore, West Bengal, India.
Subinay ChhauleDepartment of Anaesthesiology, College of Medicine and Sagore Dutta Hospital, Berhampore, West Bengal, India.
Tapobrata MitraDepartment of Anaesthesiology, Murshidabad Medical College, Berhampore, West Bengal, India.
Anindya MukherjeeDepartment of Anaesthesiology, N.R.S. Medical College, Kolkata, West Bengal, India.
Subrata Kumar MandalDepartment of Anaesthesiology, College of Medicine and Sagore Dutta Hospital, Berhampore, West Bengal, India.
Sandip ChattopadhyayDepartment of Gynecology and Obstetrics, College of Medicine and Sagore Dutta Hospital, Berhampore, West Bengal, India.
College of Medicine & Sagore Dutta Hospital · INMedical College and Hospital, Kolkata · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHead and neck cancer (HNC) surgery is associated with high intraoperative blood loss which may require urgent blood transfusion. Many strategies have been recommended to decrease the need for allogenic transfusion. Use of perioperative tranexamic acid (TA) has a promising role.

aimsThis study was to evaluate the effectiveness of single preoperative bolus dose of TA on blood loss prevention and red blood cell transfusion in patients undergoing HNC surgery. STUDY

designA prospective, double-blind, and randomized controlled study. MATERIALS AND

methodsFrom 2007 July to 2010 January; 80 patients, aged (35-55), of American Society of Anesthesiologists II-III scheduled for unilateral HNC surgeries were randomly received either TA (Group T) in a dose of 20 mg/kg diluted to 25 cc with normal saline or an equivalent volume of normal saline (Group C) in a tertiary care hospital. Hemoglobin (Hb) concentration, platelet count, packed cell volume, fibrinogen level, D-dimer level were measured pre- and post-operatively.

resultsSaline (C) Group required more blood, colloid, crystalloid for blood loss. In Group T, 32 patients did not require transfusion of any blood products compared to five patients in Group C (P < 0.0001) and only eight units of blood was transfused in Group T, whereas a total of 42 units of blood was transfused in Group C. Even after numerous transfusions, Hb% after 6 h and 24 h in Group C were significantly low in comparison with Group T (P < 0.05).

conclusionThus, TA significantly reduces blood loss and chances of colloid, blood, and crystalloid transfusion caused by HNC surgery.

Indexed as

Head neck cancer surgeryhemorrhagetranexamic acid

Identifiers

PMID26712979
PMCPMC4683496
OpenAlexW2197654077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.